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Abstract
Sarcoidosis is a systemic granulomatous disease of unknown cause. Mammary 
involvement is rare, less than 1% of all cases. In addition, it makes necessary an 
appropriate differential diagnosis in order to rule out malignant pathology as 
the main diagnosis. Therefore, it is necessary to carry out different tests as mam-
mography, ultrasound, and histological confirmation if necessary. When the 
diagnosis of mammary sarcoidosis is suspected by fine needle aspiration cytology, 
exceptional procedures should be also considered to examine for the possibility 
of a coexisting carcinoma. In such cases, excisional biopsy or resection is strongly 
recommended. There are some cases of mammary sarcoidosis associated with 
breast cancer. Breast cancer may develop in patients with sarcoidosis, sarcoidosis 
may develop in patients with breast cancer, the two diseases may develop in 
tandem, or breast cancer may induce a sarcoidosis-like granulomatous response. 
Sarcoidosis is possibly linked to silicone gel breast implants. The silicone might 
cause a sarcoidlike reaction as the result of an acceleration of an already existing 
hypersensitivity response, resulting in mammary sarcoidosis. The management 
of sarcoidosis in the breast usually is an excisional biopsy. At the same time, we 
confirm diagnosis and the treatment is done. The prognosis of mammary sarcoid-
osis remains unknown.
Keywords: breast sarcoidosis, granulomatous disease, mammary gland, granuloma, 
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1. Introduction
Sarcoidosis is a multisystemic granulomatous disorder of unknown etiology [1]. 
Our understanding of the pathogenesis of sarcoidosis has advanced and provided 
new insights into potential causes of this disease. It is important to remember that 
any etiologic agent of sarcoidosis must be capable of causing the pathologic hall-
mark of systemic noncaseating granulomas and the heterogeneous clinical features 
of sarcoidosis [2]. It is caused by alteration of the cellular immune response after 
exposure to an environmental, occupational, or infectious hazard and can involve 
multiple tissues and organs, including breast tissue [3].
About 80–90% of patients present lung or hiliar lymph nodes affected. These 
are the most common systems involved. However, the involvement of skin, eyes, 
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nervous system, locomotor system, lacrimal and salivary glands, heart, and kidney 
in sarcoidosis has also been described [1].
Sarcoid involvement of the breast parenchyma has been extremely rare in 
patients with sarcoidosis, less than 1% of the overall diagnosed patients. It is more 
common in African American, Afro-Caribbean, Swedish, and Danish individuals. 
It typically presents in women in their third and fourth decade of life and can often 
mimic breast carcinoma [4].
The descriptions of breast sarcoid vary in the literature from masses with ill-
defined margins or spiculated as seen in cancer, negative imaging, or other non-
specific appearances [3]. The most common presentation is a palpable breast mass. 
Because sarcoidosis can mimic breast cancer, it makes the differential diagnosis very 
difficult [3].
2. Etiology
Since sarcoidosis was first described more than a century ago, the etiologic 
determinants causing this disease remain uncertain. Studies suggest that genetic, 
host immunologic, and environmental factors interact together to cause sarcoidosis. 
Immunologic characteristics of sarcoidosis include noncaseating granulomas, 
enhanced local expression of T helper-1 (and often Th17) cytokines and chemo-
kines, dysfunctional regulatory T-cell responses, dysregulated Toll-like receptor 
signaling, and oligoclonal expansion of CD4+ T cells consistent with chronic 
antigenic stimulation. Multiple environmental agents have been suggested to 
cause sarcoidosis. Studies from several groups implicate mycobacterial or propi-
onibacterial organisms in the etiology of sarcoidosis based on tissue analyses and 
immunologic responses in sarcoidosis patients. Despite these studies, there is no 
consensus on the nature of a microbial pathogenesis of sarcoidosis. Some groups 
postulate sarcoidosis is caused by an active viable replicating infection, while other 
groups contend there is no clinical, pathologic, or microbiologic evidence for such a 
pathogenic mechanism [2]. The authors posit a novel hypothesis that proposes that 
sarcoidosis is triggered by a hyperimmune Th1 response to pathogenic microbial 
and tissue antigens associated with the aberrant aggregation of serum amyloid A 
within granulomas, which promotes progressive chronic granulomatous inflamma-
tion in the absence of ongoing infection.
3. Clinical manifestations
In the breast, the clinical presentation is a breast mass that could be isolated or 
multiple and unilateral or bilateral. Most of the patients do not present infectious 
or inflammatory symptoms. Moreover the nodules are not painful. It is very impor-
tant to be alert of the possible systemic symptoms that our patient may present. 
Sometimes breast sarcoidosis is the first diagnosis disease, but most times, the 
diagnosis is already done.
4. Diagnosis
The clinical impact of sarcoidosis is directly related to the extent of granuloma-
tous inflammation and its effect on the function of vital organs.
In each patient, the sites and the severity of granulomatous involvement 
throughout the body must be assessed to determine the impact of sarcoidosis on 
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systems that most greatly affect the patient’s activities and quality of life or that may 
lead to premature death.
In the breast, the most common symptom is a breast mass. It could be only one 
or multiple tumors. Therefore it is very important to make a correct differential 
diagnosis.
First of all, the physical examination probably discloses a non-tender, firm, 
and mobile lesion, with no nipple abnormalities. The patient could or not present 
axillary lymph nodes. But in some cases the lesions were fixed or tender, clinically 
resembling a carcinoma.
Then, we should perform some image techniques.
Mammography, most of the time, is the first test and usually shows a 
nonspecific, ill-defined mass with low density, poorly outlined with no 
microcalcification.
We have the same problem with ultrasound examination that does not sup-
port an unequivocal diagnosis, but we are able to point out the irregularity of the 
contours, hypoechoic spiculation, and nonhomogeneous internal echostructure of 
the nodule [5] (Figure 1).
The next step is the high-field system MR but always complementary to the 
previous ones.
Images can reveal the lesion to be a solitary signal-intensive inhomogeneous 
tumor with irregular contours, fast contrast enhancement, and an early “wash-
out” phenomenon often observed in carcinomas or in inflammatory lesions of 
the breast.
After that, it is important not to forget that the imaging techniques do not offer a 
definitive diagnosis and we must correlate it with pathological diagnosis.
To rule out infection origin, we should perform microbiologic test as stains for 
fungi and acid-fast bacilli.
Biopsy of the breast demonstrates chronic granulomatous inflammatory process, 
with epithelioid granulomas and non-necrotizing giant cells (Figure 2).
Breast sarcoidosis is very uncommon; most of the times, a fine needle biopsy is 
not enough, so an excisional biopsy is necessary.
Figure 1. 
Ultrasound examination with two nonspecific hypoechoic masses.
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The diagnosis is based on typical radiologic manifestations supported by 
histologic evidence of noncaseating granulomas in the absence of infection and 
exclusion of other types of granulomatous affections [6].
5. Differential diagnosis
There are some diseases that we should rule out when we are thinking about the 
diagnosis of sarcoidosis in the breast. Then, we break down each one of them.
5.1 Malignant pathology
First of all, the most important and the most frequent is malignant pathology 
of the breast. The American Cancer Society (ACS) estimates that 268,600 women 
will receive a diagnosis of invasive breast cancer and 62,930 people will receive a 
diagnosis of noninvasive cancer in one year. When we diagnose a breast mass, we 
suspect breast cancer. The initial test is mammography, ultrasound, and sometimes 
MRI. As we have previously objectified, there are no defined patterns in the imag-
ing test for sarcoidosis in the breast, and we have the same problem with cancer. 
Therefore, we obtain a suspicious diagnosis that we need to confirm. After those 
techniques, we perform further tests like pathological test and immunohisto-
chemistry to establish the definitive diagnosis, prognosis parameters, and correct 
therapy.
5.2 Idiopathic granulomatous mastitis (IGM)
Idiopathic granulomatous mastitis is a rare, chronic benign breast disease, which 
may mimic a breast abscess, malignancy, or other granulomatous pathologies. 
Most patients present in the third or fourth decade of life, and it typically is seen 
in women of childbearing potential from 6 months to 6 years postpartum. It is a 
diagnosis of exclusion and requires a high index of suspicion [7, 8].
Early misdiagnosis as bacterial mastitis is common, prompting multiple anti-
biotic regimens. When antibiotics fail, patients are worked up for inflammatory 
Figure 2. 
Chronic granulomatous inflammatory process, with epithelioid granulomas and non-necrotizing giant cells.
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breast cancer, given the nonhealing breast nodules. Mammography, ultrasonogra-
phy, and fine needle aspiration often are unable to rule out carcinoma, warranting 
excisional biopsies of nodules. After that, we exclude malignancy and suspect a 
potential sarcoidosis or IGM.
Idiopathic granulomatous mastitis is a diagnosis of exclusion, made after obtain-
ing evidence of granulomatous inflammation on breast biopsy and ruling out other 
granulomatous disorders, such as tuberculosis and sarcoidosis.
Almost the totality of sarcoid patients (90%) has lung disease; when we suspect 
a sarcoidosis, a chest radiograph is needed to screen for hilar lymphadenopathy and 
sometimes an ophthalmology evaluation [8].
Many cases self-resolve, but more severe cases can persist for a long period 
before adequate symptomatic treatment is achieved by methotrexate, corticoste-
roids, or surgical excision.
5.3 Tuberculosis
Breast tuberculosis (TB) is another disease characterized by the presence of 
granulomas. This pathology is rare but increasingly reported in Western Europe, 
accounting for 4.5% of all breast lesions in TB-endemic areas and 0.1% in the 
developed world.
The presenting features may mimic other breast pathologies including bacterial 
abscess, idiopathic granulomatous mastitis, sarcoidosis, or carcinoma, making 
diagnosis challenging. Risk factors for the development of breast TB include immu-
nosuppression, lactation, multiparty, and previous exposure to TB [9, 10].
The most frequent symptom is an isolated mass, with less evidence of inflamma-
tion or infection than in other types of infectious mastitis. To this, we must associ-
ate that they do not present systemic symptoms.
Diagnosis of breast TB is difficult, often necessitating multiple clinic consul-
tations and tissue sampling procedures. This frequently results in delays in TB 
treatment.
5.4 Sarcoidosis-like reaction
A phenomenon known as autoimmune/inflammatory syndrome induced by 
adjuvants may underlie the association between silicone implants and sarcoidosis-
like reaction with foreign body granulomatous reaction, in which silicone serves as 
an immunologic adjuvant to enhance antigen-specific immune response. This leads 
to enhanced production and activation of both B and T cells [11].
There are some case reports in the literature that describe this reaction, and 
it may take place in the breast skin, subcutaneous tissue, and also in axillary 
lymph nodes.
6. Treatment
The treatment of breast sarcoidosis is similar to systemic sarcoidosis, but most 
of the time, an excisional biopsy has to be done to confirm the diagnosis, and if the 
sarcoidosis is isolated in the breast, then other treatments is not necessary.
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